Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops ...

A Texas A&M committee ruled that the university’s decision to fire a professor after a student was removed from class for objecting to a children’s literature lesson on gender identity was unjustified ...

The professor will no longer be able to teach a class on diversity after she showed students a diagram that included the “Make America Great Again” slogan as an example of white supremacy. By ...

Hyundai is launching a slate of new vehicles, ranging from EVs to plug-in hybrids (PHEVs) and even fuel-cell electric vehicles. First launched in 2018, the Nexo marked a milestone as Hyundai’s first ...

Cowboys defensive end Marshawn Kneeland dead at 24 Tesla Shareholders Approve Elon Musk’s $1 Trillion Pay Package 10 Secrets McDonald’s Employees Aren't Supposed To Tell You Republicans, including ...

Beyond nominating video games for different categories of awards, The Game Awards has also propagated a Future Class in the past. Those recognized as a part of the Future Class cohort were meant to ...

State-owned Saudi Agricultural & Livestock Investment Co. plans to pursue a full ownership stake in the agribusiness unit of Singapore’s Olam Group Ltd., according to people familiar with the matter.

Thousands of Tesla owners have reportedly joined a class action lawsuit against the automaker in Australia over false claims about its ‘Full Self-Driving’ (FSD) package. Tesla is facing mounting legal ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Get ready for new wild disasters in an all-new location, “9-1-1” is headed to Tennessee in the latest entry in the TV franchise, “9-1-1: Nashville.” Like the flagship series, “9-1-1: Nashville” ...